For Victoza Type 2 diabetes Prescribing and dispensing information Prescribing and dispensing information For liraglutide. Liraglutide is a biological medicine.
Victoza (liraglutide [rDNA origin] injection) Please see enclosed Important Safety Information, Prescribing Information, and Medication. Guide for Victoza.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2024 -CELL TUMORS . prescribing information for complete boxed warning.
Victoza (liraglutide [rDNA origin] injection) Please see enclosed Important Safety Information, Prescribing Information, and Medication. Guide for Victoza.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2024 -CELL TUMORS . prescribing information for complete boxed warning.
These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA . VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2024 WARNING: RISK OF THYROID C CELL TUMORS See full prescribing information for complete boxed warning.
Victoza (liraglutide) is an anti-diabetic medication prescribed for managing information to the users.
Please see Prescribing Information and Medication Guide for Victoza. Victoza is a prescription medication. You are encouraged to report negative side
VICTOZA- liraglutide injection Novo Nordisk-HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2024 WARNING: RISK OF THYROID C-CELL TUMORS
Comments